92
Publications
5.8K
Citations
36
H-Index
2005
Active since
Julie Kanter is an author at University of Alabama at Birmingham specializing in medicine, hematology, and public health.
Top concepts
MedicineHematologyPublic HealthPediatricsHealth PolicyOutcomes ResearchHealthEpidemiologyPathologyThrombosis
Publications per year
2005–2025
92
92
Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease
Kenneth I. Ataga, Abdullah Kutlar, Julie Kanter et al. · New England Journal of Medicine · 2016 · 837 citations · Full text
A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease
Elliott Vichinsky, Carolyn Hoppe, Kenneth I. Ataga et al. · New England Journal of Medicine · 2019 · 581 citations · Full text
A Phase 3 Trial of <scp>l</scp> -Glutamine in Sickle Cell Disease
Yutaka Niihara, Scott T. Miller, Julie Kanter et al. · New England Journal of Medicine · 2018 · 522 citations · Full text
Vivek Patel, Matthieu Mahévas, Soo Yong Lee et al. · Blood · 2012 · 337 citations · Full text
Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab
Rebecca Marsh, Carl E. Allen, Kenneth L. McClain et al. · Pediatric Blood & Cancer · 2012 · 302 citations · Full text
Rows per page
1–5 of 92